PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17478939-0	2007	[Effect of ranitidine on the gastric acid, plasma endothelin, and calcitonin gene-related peptide in patients undergoing the brain operation].	Ranitidine	11-21	calcitonin related polypeptide alpha	Homo sapiens	66-97	
17478939-9	2007	Ranitidine can obviously decrease the level of intra-gastric acid, and improve the macrocirculation of gastric mucous membrane by decreasing ET and increasing the CGRP level.	Ranitidine	0-10	calcitonin related polypeptide alpha	Homo sapiens	163-167	
12495560-5	2002	The administration of ranitidine and nizatidine caused significant increases in plasma CGRP and SP levels at 30 to 120 min compared with the placebo group.	Ranitidine	22-32	calcitonin related polypeptide alpha	Homo sapiens	87-91	
12495560-6	2002	Peak plasma CGRP levels (39.8+/-3.1 and 40.6+/-3.6 pg mL(-1)) were achieved 60 min after administration of ranitidine and nizatidine, respectively.	Ranitidine	107-117	calcitonin related polypeptide alpha	Homo sapiens	12-16	
12495560-9	2002	The released CGRP and SP by ranitidine and nizatidine administration may produce a gastroprotective effect, increase mucosal blood flow, and inhibit acid secretion in the gastrointestinal tract.	Ranitidine	28-38	calcitonin related polypeptide alpha	Homo sapiens	13-17	
17478939-1	2007	OBJECTIVE: To observe the effect of ranitidine on gastric acid, plasma endothelin, and calcitonin gene-related peptide (CGRP) in patients undergoing the brain operation, and to explore the possible pathogenesis of ranitidine on preventing from gastric mucosal injury under the stress.	Ranitidine	36-46	calcitonin related polypeptide alpha	Homo sapiens	120-124